Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to innovating therapies for patients with autoimmune diseases and amyotrophic lateral sclerosis (ALS), particularly those in need of organ or cell transplantation. Based in Irvine, California, Eledon is advancing its proprietary drug candidates through clinical trials, aiming to address significant unmet medical needs in these patient populations. With a robust pipeline and a strategic focus on enhancing transplant outcomes, Eledon is positioned to make a meaningful impact in the biopharmaceutical landscape.
Click "Analyze" to generate stock analysis
ELDN Price Trend and Signals
ELDN Option Volumes & Open Interests (aggregated)
ELDN Put Call Ratios and IV (aggregated)
ELDN Financials
2025-10-29Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-28Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-27Somewhat Bullishprice_signal
Quarterly high detected.
2025-10-20Somewhat Bullishprice_signal
Monthly high detected.
2025-10-17Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-17Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-17Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-17Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.